What is DNA 3D Printing Market?
DNA 3D printing is a combination of laser technology and 3D printers. It is made for printing the human genome at much simpler methods as compared to the traditional method of DNA synthesis. The process of DNA 3D printing includes millions of strands that are formed mixing the DNA sequence. They are further detached from the growth array and are made to attach to a one-micron wide bead. The attached bead is cloned to the strand itself which is further cloned, so each bead has multiple copies of the original attached to it. The beads are moved to a glass slide and the laser printer detects the DNA and zaps the beads containing the accurate DNA, thereby sending the good DNA into collection flow cells, removing the defective DNA. Further, with the rising prevalence of genetic disorders and advancement in molecular biology the DNA 3D printing market is anticipated to foster the market growth in the forecast period.
The market study is being classified by Type (3D Printer, Laser Technology, DNA Sample and Enzyme), by Application (Bioengineering / R&D, Pharmaceutical Drugs/ Therapies, Agriculture Industry, Energy and Others [Education industry (Virtual classes) for Biology Lessons, etc.]) and major geographies with country level break-up.
Pensar Development (United States), Cambrian Genomics Inc. (United States), 3D Systems, Inc. (United States), Jakajima B.V (Netherlands), Arevo, Inc. (United States), Imaginarium (India) and axial3D- Medical 3D Printing Experts Ltd. (United Kingdom) are some of the key players profiled in the study.
The DNA 3D printing market is concentrated with few players, as the market is witnessing robust growth over the forecast timeline due to the rising adoption of innovative technologies. As the innovations in DNA 3D printing are leading to bring down the cost of constructing DNA strands, these entrepreneurs are aiming for a low price point. This will act as a growth rendering factor over the forecast period.
Segment Analysis
Analyst at AMA have segmented the market study of Global DNA 3D Printing market by Type, Application and Region.
On the basis of geography, the market of DNA 3D Printing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increasing Demand for DNA 3D Printers among Researchers and Bioengineers
- Rising Prevalence of Genetic Disorders
- Growing Demand due to High Accuracy than the Traditional Method for DNA Synthesis
- Evolution in the Genetic Therapies Leading to Speeding Treatment Rate
Market Trend
- Rapid Advancements in Molecular Biology Tools Such as Next Generation Sequencing
- Deployment of DNA 3D Printing as Scaffold for Nanoparticles
- The Advent of Custom-Made Genes to Produce Chemicals, Biologic Drugs or Industrial Enzymes
Restraints
- High Cost of DNA 3D Printing Machine may hinder the Market Growth
Opportunities
- Technological Advancements in Biomedical Applications of DNA 3D Printing
- Collaboration Between Manufacturing Industries to Increase Product Development such as Faster Genetic-based Drug Production
Challenges
- The Discrepancy in the Result Obtained from DNA 3D Printing
- Complexity and Time-Consuming Process
Market Leaders and some development strategies
June 2018, UC Berkeley and Lawrence Berkeley National Laboratory developed a new way to synthesize DNA i.e DNA 3D Printing. The method could lead to DNA printers, similar to ordinary 3D printers, that could produce DNA strands that are more accurate and 10 times longer than the strands produced with new methods, more quickly and easily, and without the use of toxic chemicals
Key Target Audience
DNA 3D Printing Manufacturers, Research Organizations, Pharmaceutical Companies, Potential Investors, Downstream Vendors, Government and Regulatory Bodies and Others